AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (November 10, 2006). doi:10.1152/ajpheart.01056.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/3/H1443    most recent
01056.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sekiguchi, K.
Right arrow Articles by Barger, P. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sekiguchi, K.
Right arrow Articles by Barger, P. M
Submitted on September 26, 2006
Accepted on November 6, 2006

Inhibition of PPAR{alpha} activity in mice with cardiac-restricted expression of Tumor Necrosis Factor: potential role of TGF{beta}/Smad3

Kenichi Sekiguchi, Qi Tian1, Masakuni Ishiyama, Jana Burchfield, Feng Gao1, Douglas L. Mann2, and Philip M Barger1*

1 Medicine, Baylor College of Medicine, Houston, Texas, United States
2 Medicine, Baylor College of Medicine, Houston, United States

* To whom correspondence should be addressed. E-mail: pbarger{at}bcm.edu.

A shift in energy substrate utilization from fatty acids to glucose has been reported in failing hearts, resulting in improved oxygen efficiency, yet perhaps also contributing to a state of energy deficiency. PPAR{alpha}, the principal transcriptional regulator of cardiac fatty acid {beta}-oxidation (FAO) genes, is down regulated in heart failure and this may contribute to reduced fatty acid utilization. Cardiomyopathic states are also accompanied by elevated levels of circulating cytokines, such as tumor necrosis factor (TNF), as well as increased local production of cytokines and pro-fibrotic factors, such as TGF{beta}. However, whether these molecular pathways directly modulate cardiac energy metabolism and PPAR{alpha} activity is not known. Therefore, FAO capacity and FAO gene expression were determined in mice with cardiac-restricted over expression of TNF (MHCsTNF3). MHCsTNF3 hearts had significantly lower FAO capacity and decreased expression of PPAR{alpha} and FAO target genes compared to control hearts. Surprisingly, TNF had little effect on PPAR{alpha} activity and FAO rates in cultured ventricular myocytes, suggesting that TNF acts indirectly on myocyte FAO in vivo. We found that TGF{beta} expression was upregulated in MHCsTNF3 hearts and that treatment of cultured myocytes with TGF{beta} significantly suppressed FAO rates and directly impaired PPAR{alpha} activity, a result reproduced by Smad3 over expression. This work demonstrates that TGF{beta} signaling pathways directly suppress PPAR{alpha} activity and reduce FAO in cardiac myocytes, perhaps in response to locally elevated TNF. Although speculative, TGF{beta} driven repair mechanisms may also include the additional benefit of limiting FAO in injured myocardium.




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
C. Pellieux, C. Montessuit, I. Papageorgiou, and R. Lerch
Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-{alpha}
Cardiovasc Res, May 1, 2009; 82(2): 341 - 350.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. K. LeBrasseur, T.-A. S. Duhaney, D. S. De Silva, L. Cui, P. C. Ip, L. Joseph, and F. Sam
Effects of Fenofibrate on Cardiac Remodeling in Aldosterone-Induced Hypertension
Hypertension, September 1, 2007; 50(3): 489 - 496.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. H. Remels, P. Schrauwen, R. Broekhuizen, J. Willems, S. Kersten, H. R. Gosker, and A. M. Schols
Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD
Eur. Respir. J., August 1, 2007; 30(2): 245 - 252.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.